Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia.
Chen H
,
von Hehn C
,
Kaczmarek LK
,
Ment LR
,
Pober BR
,
Hisama FM
.
???displayArticle.abstract???
Myokymia is characterized by spontaneous, involuntary muscle fiber group contraction visible as vermiform movement of the overlying skin. Myokymia with episodic ataxia is a rare, autosomal dominant trait caused by mutations in KCNA1, encoding a voltage-gated potassium channel. In the present study, we report a family with four members affected with myokymia. Additional clinical features included motor delay initially diagnosed as cerebral palsy, worsening with febrile illness, persistent extensor plantar reflex, and absence of epilepsy or episodic ataxia. Mutation analysis revealed a novel c.676C>A substitution in the potassium channel gene KCNA1, resulting in a T226K nonconservative missense mutation in the Kv1.1 subunit in all affected individuals. Electrophysiological studies of the mutant channel expressed in Xenopus oocytes indicated a loss of function. Co-expression of WT and mutant cRNAs significantly reduced whole-oocyte current compared to expression of WT Kv1.1 alone.
Fig. 1. Family pedigree. Squares indicate males, circles indicate females. Blackened symbols denote individuals with myokymia. Alleles at codon 226 are indicated (Thr = wild-type, Lys = mutation)
Fig. 2. Sequence chromatograms demonstrating c.676C>A resulting in T226K substitution in KCNA1. A DNA sequence from an affected patient (I-2) heterozygous for the mutation (top) and from a normal control (bottom) are presented
Fig. 3. Missense mutation T226K induces loss of function of human Kv1.1 channels expressed in Xenopus oocytes. aâc Representative family of whole-oocyte currents recorded from oocytes expressing human Kv1.1-WT (a), Kv1.1-T226K (b), and both Kv1.1 WT and T226K (c). Currents were evoked by a series of 350-ms test pulses from â80 to +60 mV in 10-mV increments from a hold potential of â90 mV. Tail currents were recoded at â40 mV. Scale bar, 100 ms and 1 μA. d IâV curves for three experimental conditions in aâc. Data were collected for 10â15 oocytes in each group. The peak currents in a and c are significantly different at test voltages between 0 and +60 mV (Pâ<â0.05)
Browne,
Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1.
1994, Pubmed
Browne,
Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1.
1994,
Pubmed
Comu,
Episodic ataxia and myokymia syndrome: a new mutation of potassium channel gene Kv1.1.
1996,
Pubmed
Dedek,
Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel.
2001,
Pubmed
,
Xenbase
Eunson,
Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability.
2000,
Pubmed
Hallows,
Expression of Kv1.1, a Shaker-like potassium channel, is temporally regulated in embryonic neurons and glia.
1998,
Pubmed
Kaczmarek,
Policing the ball: a new potassium channel subunit determines inactivation rate.
2006,
Pubmed
Kaczmarek,
Non-conducting functions of voltage-gated ion channels.
2006,
Pubmed
Kinali,
Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia.
2004,
Pubmed
Klein,
Episodic ataxia type 1 with distal weakness: a novel manifestation of a potassium channelopathy.
2004,
Pubmed
Lee,
A novel mutation in KCNA1 causes episodic ataxia without myokymia.
2004,
Pubmed
Rho,
Developmental seizure susceptibility of kv1.1 potassium channel knockout mice.
1999,
Pubmed
Scheffer,
Three novel KCNA1 mutations in episodic ataxia type I families.
1998,
Pubmed
van Brederode,
Evidence of altered inhibition in layer V pyramidal neurons from neocortex of Kcna1-null mice.
2001,
Pubmed
VanDyke,
Hereditary myokymia and periodic ataxia.
1975,
Pubmed
Vernino,
Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability.
2002,
Pubmed
Zerr,
Characterization of three episodic ataxia mutations in the human Kv1.1 potassium channel.
1998,
Pubmed
,
Xenbase
Zuberi,
A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy.
1999,
Pubmed
